International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 1 , Pages 288-295 , 1 January 2009

Radiosensitization by Inhibiting STAT1 in Renal Cell Carcinoma

  • Zhouguang Hui, M.D., Ph.D.

      Affiliations

    • Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine, Houston, TX
    • Department of Radiation Oncology, Cancer Hospital (Institute), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China
    • ,
  • Maria Tretiakova, M.D., Ph.D.

      Affiliations

    • Department of Pathology, University of Chicago Pritzker School of Medicine, Chicago, IL
    • ,
  • Zhongfa Zhang, Ph.D.

      Affiliations

    • Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, MI
    • ,
  • Yan Li, Ph.D.

      Affiliations

    • Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, MI
    • ,
  • Xiaozhen Wang, M.D., Ph.D.

      Affiliations

    • Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine, Houston, TX
    • Department of Radiation Oncology, Cancer Hospital (Institute), Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, People's Republic of China
    • ,
  • Julie Xiaohong Zhu, M.D.

      Affiliations

    • Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine, Houston, TX
    • ,
  • Yuanhong Gao, M.D., Ph.D.

      Affiliations

    • Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine, Houston, TX
    • Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China
    • ,
  • Weiyuan Mai, M.D.

      Affiliations

    • Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine, Houston, TX
    • ,
  • Kyle Furge, Ph.D.

      Affiliations

    • Laboratory of Computational Biology, Van Andel Research Institute, Grand Rapids, MI
    • ,
  • Chao-Nan Qian, M.D., Ph.D.

      Affiliations

    • Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, MI
    • Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, People's Republic of China
    • ,
  • Robert Amato, D.O.

      Affiliations

    • Department of Genitourinary Oncology, Methodist Hospital, Houston, TX
    • ,
  • E. Brian Butler, M.D.

      Affiliations

    • Department of Radiation Oncology, Methodist Hospital and Methodist Hospital Research Institute, Houston, TX
    • ,
  • Bin Tean Teh, M.D., Ph.D.

      Affiliations

    • Laboratory of Cancer Genetics, Van Andel Research Institute, Grand Rapids, MI
    • ,
  • Bin S. Teh, M.D.

      Affiliations

    • Department of Radiology, Division of Radiation Oncology, Baylor College of Medicine, Houston, TX
    • Department of Radiation Oncology, Methodist Hospital and Methodist Hospital Research Institute, Houston, TX
    • Laboratory of Radiation Biology Research, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX
    • Corresponding Author InformationReprint requests to: Bin S. Teh, M.D., Department of Radiation Oncology, Methodist Hospital, 6565 Fannin St., Houston, TX 77030. Tel: (713) 790-2637; Fax: (713) 793-1300

Received 10 December 2007 ,Revised 26 August 2008 ,Accepted 28 August 2008.

References 

  1. Michael B, Kastan JB. Cell-cycle checkpoints and cancer. Nature. 2004;432:316–323
  2. Valerie K, Povirk L. Regulation and mechanisms of mammalian double-strand break repair. Oncogene. 2003;22:5792–5812
  3. Takahashi M, Yang XJ, Sugimura J, et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene. 2003;22:6810–6918
  4. Khodarev NN, Beckett M, Labay E, et al. STAT1 is overexpressed in tumors selected for radioresistance and confer protection from radiation in transduced sensitive cells. PNAS. 2004;101:1714–1719
  5. Yang XJ, Sugimura J, Schafernak KT, et al. Classification of renal neoplasms based on molecular signatures. J Urol. 2006;175:2302–2306
  6. Arany I, Chen SH, Megyesi JK, et al. Differentiation-dependent expression of signal transducers and activators of transcription (STATs) might modify responses to growth factors in the cancers of the head and neck. Cancer Lett. 2003;199:83–89
  7. Laimer K, Spizzo G, Obrist P, et al. STAT1 activation in squamous cell cancer of the oral cavity: A potential predictive marker of response to adjuvant chemotherapy. Cancer Lett. 2007;110:326–333
  8. Harris AL. Hypoxia—A key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2:38–47
  9. Hall EJ, Giaccia AJ. Radiobiology for the radiobiologist. 6th ed.. Philadelphia: Lippincott Williams & Wilkins; 2005;
  10. Amundson SA, Bittner M, Fornace AJ. Functional genomics as a window on radiation stress signaling. Oncogene. 2003;22:5828–5833
  11. Ahmed MM, Alcock RA, Chendil D, et al. Restoration of transforming growth factor-beta signaling enhances radiosensitivity by altering the Bcl-2/Bax ratio in the p53 mutant pancreatic cancer cell line MIA PaCa-2. J Biol Chem. 2002;277:2234–2246
  12. Wahl GM, Carr AM. The evolution of diverse biological responses to DNA damage: Insights from yeast and p53. Nat Cell Biol. 2001;3:E277–E286
  13. Haas-Kogan DA, Kogan SS, Yount G, et al. p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors. Int J Radiat Oncol Biol Phys. 1999;43:399–403
  14. Duda DG, Jain RK, Willett CG. Antiangiogenics: The potential role of integrating this novel treatment modality with chemoradiation for solid cancers. J Clin Oncol. 2007;25:4033–4042
  15. Shewach DS, Lawrence TS. Antimetabolite radiosensitizers. J Clin Oncol. 2007;25:4043–4050
  16. Amorino GP, Hamilton VM, Valerie K, et al. Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells. Mol Biol Cell. 2002;13:2233–2244
  17. Costa-Pereira AP, Tininini S, Strobl B, et al. Mutational switch of an IL-6 response to an interferon-r-like response. Proc Natl Acad Sci. 2002;99:8043–8047
  18. Messina JL, Yu H, Riker AI, et al. Activated Stat-3 in melanoma. Cancer Control. 2008;15:196–201
  19. Frank DA, Mahajan S, Ritz J. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med. 1999;5:444–447
  20. Darnell JE. STATs and gene regulation. Science. 1997;277:1630–1635
  21. Martinez-Lostao L, Briones J, Forné I, et al. Role of the STAT1 pathway in apoptosis induced by fludarabine and JAK kinase inhibitors in B-cell chronic lymphocytic leukemia. Leukemia Lymphoma. 2005;46:435–442
  22. Terui K, Haga S, Enosawa S, et al. Hypoxia/re-oxygenation-induced, redox-dependent activation of STAT1 (signal transducer and activator of transcription 1) confers resistance to apoptotic cell death via hsp70 induction. Biochem J. 2004;380:203–209
  23. Fagard R, Mouas H, Dusanter-Fourt I, et al. Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells. Oncogene. 2002;21:4473–4480
  24. Nishioka C, IkezoT Togitani K, et al. Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kB. Bone Marrow Transplant. 2008;41:303–309
  25. Tsai MH, Cook JA, Chandramouli GV, et al. Gene expression profiling of breast, prostate, and glioma cells following single versus fractionated doses of radiation. Cancer Res. 2007;67:3845–3852
  26. Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res. 2002;8:945–954
  27. Battle TE, Frank DA. The role of STATs in apoptosis. Curr Mol Med. 2002;2:381–392
  28. El-Hashemite N, Zhang H, Walker V, et al. Perturbed IFN-gamma-Jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models: Synergistic effects of rapamycin-IFN-gamma treatment. Cancer Res. 2004;64:3436–3443
  29. Cochet O, Frelin C, Peyron JF, et al. Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival. Cell Signal. 2006;18:449–455
  30. Legrand A, Vadrot N, Lardeux B, et al. Study of the effects of interferon α on several human hepatoma cell lines: Analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation. Liver Int. 2004;24:149–160
  31. Townsend PA, McComick J, Barry S, et al. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage. J Cell Sci. 2005;118:1629–1639

 Supported by a research grant from the Methodist Hospital Research Institute, and also the Gerber Foundation, Hauenstein Foundation, Michigan Economic Development Corporation, and Michigan Technology Tri-Corridor to B. T. Teh. Supported by National Natural Science Foundation of China for Young Scholar (30800280) to Z. Hui.

 Presented in part at the 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, November 5–9, 2006, Philadelphia, PA.

 Conflict of interest: none, except B. S. Teh received a Methodist Hospital Research Institute research grant.

PII: S0360-3016(08)03432-9

doi: 10.1016/j.ijrobp.2008.08.043

International Journal of Radiation Oncology * Biology * Physics
Volume 73, Issue 1 , Pages 288-295 , 1 January 2009

Article Tools

* Image Usage & Resolution